Track BDTX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
BDTX - Black Diamond Therapeutics Inc (BDTX) has a shares outstanding of 57.23M, up 0.2% over the past year.
Shares Outstanding
57.23M
Dilution %
+2755.39%
Annual Change
+0.25%
| Year | Shares | Change |
|---|---|---|
| 2026 | 57.23M | +0.25% |
| 2025 | 57.09M | +0.85% |
| 2024 | 56.61M | +19.30% |
| 2023 | 47.45M | +30.39% |
| 2022 | 36.39M | +0.44% |
| 2021 | 36.23M | +0.57% |
| 2020 | 36.02M | +10.38% |
| 2019 | 32.64M | +133.94% |
| 2018 | 13.95M | - |
| Quarter | Shares | Change |
|---|---|---|
| Q1 2026 | 57.23M | +0.25% |
| Q4 2025 | 57.09M | +0.28% |
| Q3 2025 | 56.93M | +0.22% |
| Q2 2025 | 56.80M | -1.51% |
| Q1 2025 | 57.67M | +1.88% |
| Q4 2024 | 56.61M | +0.18% |
| Q3 2024 | 56.51M | +2.45% |
| Q2 2024 | 55.16M | +6.46% |
| Q1 2024 | 51.81M | +9.19% |
| Q4 2023 | 47.45M | -6.86% |
| Q3 2023 | 50.94M | +39.51% |
| Q2 2023 | 36.52M | +0.09% |
| Q1 2023 | 36.48M | +0.26% |
| Q4 2022 | 36.39M | +0.12% |
| Q3 2022 | 36.35M | +0.14% |
| Q2 2022 | 36.29M | +0.06% |
| Q1 2022 | 36.27M | +0.11% |
| Q4 2021 | 36.23M | +0.03% |
| Q3 2021 | 36.22M | +0.10% |
| Q2 2021 | 36.18M | +0.16% |
| Q1 2021 | 36.12M | +0.28% |
| Q4 2020 | 36.02M | +0.27% |
| Q3 2020 | 35.93M | +0.05% |
| Q2 2020 | 35.91M | +51.53% |
| Q1 2020 | 23.70M | -27.38% |
| Q4 2019 | 32.64M | +133.94% |
| Q3 2019 | 13.95M | +0.00% |
| Q2 2019 | 13.95M | +0.00% |
| Q1 2019 | 13.95M | +0.00% |
| Q4 2018 | 13.95M | +587.68% |
| Q3 2018 | 2.03M | +1.21% |
| Q2 2018 | 2.00M | +0.00% |
| Q1 2018 | 2.00M | - |
Shares outstanding is the total number of a company's shares currently held by all its shareholders. A shrinking share count usually reflects buybacks that raise each remaining share's claim on earnings, while a rising count can signal dilution.